LR

Luich Rahman

Active Director Director DIN 06884631
DIN 06884631 First appointment Aug 2014 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2014
Shareholding value •••• Premium profile

About Luich Rahman

Data last updated:

Luich Rahman is a Director at Cavalry Pharmaceuticals Private Limited (since 2014). The company operates in Chemicals. Cavalry Pharmaceuticals Private Limited reported revenue of ₹3.1 Lakh (FY 2025).

DIN 06884631
Primary Designation Director
Industry Chemicals
First Appointment 07 Aug 2014
Oldest Company Age 12 yrs
Largest company Cavalry Pharmaceuticals Private Limited · ₹3.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Aug 20142014₹3.1 Lakh (FY 2025)Active

Board colleagues of Luich Rahman

NameDINCompanyDesignation
Bappu Rahman06884620Cavalry Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cavalry Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Luich Rahman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Luich Rahman

Luich Rahman currently holds 1 directorship: Cavalry Pharmaceuticals Private Limited (Director, since 07 Aug 2014, revenue ₹3.1 Lakh (FY 2025)).

Luich Rahman was first appointed on 07 Aug 2014 as Director at Cavalry Pharmaceuticals Private Limited.

The current boards of Luich Rahman's companies include Bappu Rahman (Cavalry Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available